IMPACT OF ENGINEERED NANOMATERIALS IN GENOMICS AND EPIGENOMICS (HB 2023). This item is unavailable.IMPACT OF ENGINEERED NANOMATERIALS IN GENOMICS AND EPIGENOMICS (HB 2023)

Overview of current research and technologies in nanomaterial science as applied to omics science at the single cell level

Impact of Engineered Nanomaterials in Genomics and Epigenomics is a comprehensive and authoritative compilation of the genetic processes and instructions that specifically direct individual genes to turn on or off, focusing on the developing technologies of engineering nanomaterials and their role in cell engineering which have become important research tools for pharmaceutical, biological, medical, and toxicological studies.

Combining state-of-the art information on the impact of engineered nanomaterials in genomics and epigenomics, from a range of internationally recognized investigators from around the world, this edited volume offers unique insights into the current trends and future directions of research in this scientific field.

Impact of Engineered Nanomaterials in Genomics and Epigenomics includes detailed information on sample topics such as:

• Impact of engineered nanomaterials in genomics and epigenomics, including adverse impact on glucose energy metabolism
• Toxicogenomics, toxicoepigenomics, genotoxicity and epigenotoxicity, and mechanisms of toxicogenomics and toxicoepigenomics
• Adverse effects of engineered nanomaterials on human environment and metabolomics pathways leading to ecological toxicity
• Meta-analysis methods to identify genomic toxicity mechanisms of engineered nanomaterials and biological effects of engineered nanomaterial exposure
• Artificial intelligence and machine learning of single-cell transcriptomics of engineered nanoparticles and trends in plant nano-interaction to mitigate abiotic stresses

This comprehensive work is a valuable and excellent source of authoritative and up-to-date information for advanced students and researchers, toxicologists, the drug industry, risk assessors and regulators in academia, industry, and government, as well as for clinical scientists working in hospital and clinical environments.

Saura C. Sahu, PhD, is a former Research Chemist with the Division of Toxicology at the Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition at the United States Food and Drug Administration.